Literature DB >> 9881977

Direct suppression of Stat1 function during adenoviral infection.

D C Look1, W T Roswit, A G Frick, Y Gris-Alevy, D M Dickhaus, M J Walter, M J Holtzman.   

Abstract

The action of adenoviral E1A oncoprotein on host immune-response genes has been attributed to interaction with p300/CBP-type transcriptional coactivators in competition with endogenous transcription factors such as signal transducer and activator of transcription (STAT) proteins. However, we show that mutant forms of E1A that no longer bind p300/CBP can still interact directly with Stat1 (via E1A N-terminal and Stat1 C-terminal residues) and block IFNgamma-driven, Stat1-dependent gene activation and consequent function during early-phase infection in the natural host cell. The results provide a distinct and more specific mechanism for E1A-mediated immune suppression and an alternative model of IFNgamma-driven enhanceosome formation that may allow for other adaptors (in addition to p300/CBP) to link Stat1 to the basal transcription complex.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9881977     DOI: 10.1016/s1074-7613(00)80652-4

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  56 in total

Review 1.  Jaks, STATs, Cytokines, and Sepsis.

Authors:  Melanie J Scott; Christopher J Godshall; William G Cheadle
Journal:  Clin Diagn Lab Immunol       Date:  2002-11

2.  Constitutive activation of an epithelial signal transducer and activator of transcription (STAT) pathway in asthma.

Authors:  D Sampath; M Castro; D C Look; M J Holtzman
Journal:  J Clin Invest       Date:  1999-05       Impact factor: 14.808

3.  Mycobacterium avium subsp. paratuberculosis inhibits gamma interferon-induced signaling in bovine monocytes: insights into the cellular mechanisms of Johne's disease.

Authors:  Ryan J Arsenault; Yue Li; Kelli Bell; Kimberley Doig; Andrew Potter; Philip J Griebel; Anthony Kusalik; Scott Napper
Journal:  Infect Immun       Date:  2012-06-11       Impact factor: 3.441

4.  Virus-inducible expression of a host chemokine gene relies on replication-linked mRNA stabilization.

Authors:  T Koga; E Sardiña; R M Tidwell; M Pelletier; D C Look; M J Holtzman
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-11       Impact factor: 11.205

Review 5.  Acute and chronic airway responses to viral infection: implications for asthma and chronic obstructive pulmonary disease.

Authors:  Michael J Holtzman; Jeffrey W Tyner; Edy Y Kim; Mindy S Lo; Anand C Patel; Laurie P Shornick; Eugene Agapov; Yong Zhang
Journal:  Proc Am Thorac Soc       Date:  2005

6.  Respiratory Enterovirus (like Parainfluenza Virus) Can Cause Chronic Lung Disease if Protection by Airway Epithelial STAT1 Is Lost.

Authors:  Yong Zhang; Dailing Mao; Shamus P Keeler; Xinyu Wang; Kangyun Wu; Benjamin J Gerovac; Laurie L Shornick; Eugene V Agapov; Michael J Holtzman
Journal:  J Immunol       Date:  2019-02-25       Impact factor: 5.422

7.  Strategic attack on host cell gene expression during adenovirus infection.

Authors:  Hongxing Zhao; Fredrik Granberg; Ludmila Elfineh; Ulf Pettersson; Catharina Svensson
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

8.  Transgenic expression in mouse lung reveals distinct biological roles for the adenovirus type 5 E1A 243- and 289-amino-acid proteins.

Authors:  Yongping Yang; Colin McKerlie; Steven H Borenstein; Zhan Lu; Marco Schito; John W Chamberlain; Manuel Buchwald
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

Review 9.  Defining and adjusting divergent host responses to viral infection.

Authors:  Michael J Holtzman; Edy Y Kim; Mindy S Lo; Jeffrey W Tyner; Laurie P Shornick; Kaharu C Sumino; Yong Zhang
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

10.  Viral induction of a chronic asthma phenotype and genetic segregation from the acute response.

Authors:  Michael J Walter; Jeffrey D Morton; Naohiro Kajiwara; Eugene Agapov; Michael J Holtzman
Journal:  J Clin Invest       Date:  2002-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.